<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03327948</url>
  </required_header>
  <id_info>
    <org_study_id>105-0050</org_study_id>
    <nct_id>NCT03327948</nct_id>
  </id_info>
  <brief_title>Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt</brief_title>
  <acronym>ARTISAN-SNM</acronym>
  <official_title>Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Axonics Modulation Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Axonics Modulation Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ARTISAN-SNM study is designed to evaluate the safety and effectiveness of the Axonics
      Sacral Neuromodulation System as an aid in the treatment of the symptoms of urinary urgency
      incontinence (UUI) in patients who have failed or could not tolerate more conservative
      treatments.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 21, 2017</start_date>
  <completion_date type="Anticipated">May 21, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 21, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Responders</measure>
    <time_frame>6 month</time_frame>
    <description>Responders are defined as patients with greater than or equal to 50% reduction in symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICIQ-OAB-qol</measure>
    <time_frame>6 month</time_frame>
    <description>International Consultation on Incontinence Modular Questionnaire (ICIQ)- Overactive Bladder (OAB), Quality of Life (qol). Score range of 0-100, with greater values indicating better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of leaks</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of voids</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">145</enrollment>
  <condition>Urinary Incontinence, Urge</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Urinary Urgency Incontinence</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Axonics Sacral Neuromodulation System (SNM) System</intervention_name>
    <description>Axonics Sacral Neuromodulation System (SNM) System</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Primary Inclusion Criteria:

          1. Diagnosis of UUI demonstrated on a 72-hour voiding diary defined as a minimum of four
             (4) leaking episodes associated with urgency, at least 50% of all leaking episodes
             associated with urgency, and at least one leaking episode each 24-hour period.

          2. Greater than or equal to 6 months' history of UUI diagnosis

          3. For male subjects only: Peak flow rate &gt; 15 cc/s as verified by uroflowmetry within 6
             months prior to enrollment; Residual bladder volume &lt; 150 cc tested within 6 months
             prior to enrollment

          4. 21 years of age and older

          5. Willing and capable of providing informed consent

          6. Capable of participating in all testing associated with this clinical investigation

        Primary Exclusion Criteria:

          1. Stress incontinence or mixed incontinence.

          2. Current urinary tract mechanical obstruction (e.g. benign prostatic enlargement or
             urethral stricture)

          3. Interstitial cystitis or bladder pain syndrome as defined by either American
             Urological Association (AUA) or European Association of Urology (EAU) guidelines

          4. A female who is breastfeeding

          5. A female with a positive urine pregnancy test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Goldman, MD FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felicia Lane, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Irvine Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seth Kaufman</last_name>
    <phone>9493987808</phone>
    <email>clinicaltrials@axonicsmodulation.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UC Irvine Health</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>95134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Felicia Lane, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Goldman, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Van Kerrebroeck, MD, PhD,MMSc</last_name>
    </contact>
    <investigator>
      <last_name>Philip Van Kerrebroeck, MD, PhD,MMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2017</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sacral neuromodulation (SNM)</keyword>
  <keyword>SNM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Urge</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

